Brokers Issue Forecasts for Elevance Health FY2025 Earnings

Elevance Health, Inc. (NYSE:ELVFree Report) – Investment analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Elevance Health in a report released on Friday, January 24th. Cantor Fitzgerald analyst S. James now anticipates that the company will earn $34.57 per share for the year, down from their prior estimate of $34.65. Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share.

A number of other research analysts also recently issued reports on ELV. Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a report on Friday, January 17th. TD Cowen dropped their target price on Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research report on Monday, October 21st. Argus lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Finally, Barclays upped their target price on shares of Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a research report on Friday. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $525.60.

Read Our Latest Stock Report on ELV

Elevance Health Trading Up 0.0 %

Shares of NYSE ELV opened at $401.43 on Monday. The stock’s 50 day moving average price is $386.21 and its two-hundred day moving average price is $461.87. Elevance Health has a 52-week low of $362.21 and a 52-week high of $567.26. The stock has a market capitalization of $93.10 billion, a P/E ratio of 14.63, a PEG ratio of 1.11 and a beta of 0.84. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56.

Elevance Health (NYSE:ELVGet Free Report) last issued its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%.

Elevance Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be issued a dividend of $1.71 per share. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a yield of 1.70%. The ex-dividend date is Monday, March 10th. Elevance Health’s payout ratio is presently 23.77%.

Institutional Trading of Elevance Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Raelipskie Partnership acquired a new position in Elevance Health in the third quarter worth approximately $26,000. PSI Advisors LLC acquired a new position in shares of Elevance Health in the 3rd quarter worth $27,000. Eastern Bank acquired a new stake in shares of Elevance Health during the third quarter worth $31,000. Crews Bank & Trust acquired a new position in shares of Elevance Health in the 4th quarter valued at $34,000. Finally, Dunhill Financial LLC increased its stake in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after purchasing an additional 26 shares in the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.

About Elevance Health

(Get Free Report)

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Featured Stories

Earnings History and Estimates for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.